Manager/Senior Manager, Health Plan Growth
Aradigm
Manager/Senior Manager, Health Plan Growth
Aradigm
Cost-plus platform for CGTs affordability
Aradigm · United States (Remote) · — · Posted 2026-11-03
Workplace: remote
About Aradigm:
Aradigm is a benefits platform for cell and gene therapies (CGT) designed to provide sustainable access to life-saving medicines. Aradigm’s novel financial and delivery model addresses the challenges facing every stakeholder - payers, providers, manufacturers, and, most importantly, patients. A public benefit corporation, Aradigm is backed by Frist Cressey, Morgan Health, and Andreessen Horowitz. Learn more at www.aradigmhealth.com.
You'll report to our Head of Growth and work alongside our growth team. We're flat by design: no ladder to climb, and growth comes from scope and ownership. We work remotely within the US, with a strong preference for NYC-based candidates.
This Role:
Health plans are central to Aradigm’s growth, with this hire serving a critical role in supporting the robust and accelerating health plan pipeline. You’ll drive the regional health plan pipeline across all lines of business and build the proposals, pricing, and analysis that win partnerships, working directly with the Head of Growth and the leadership team.
What You’ll Do:
Who You Are:
Powered by Workable
Aradigm Health builds a benefits platform to make cell and gene therapies (CGTs) affordable and accessible. It operates a cost-plus, transparent pricing model and creates a large-scale risk pool to cover CGT drugs and related care, providing predictable costs for self-insured employers and health plans. Any unspent funds from the premium pool are returned to the payer. For providers, it offers a national network of “centers of excellence” and predictable reimbursement to reduce financial risk and complexity. For manufacturers, it opens new access channels to their therapies. For patients, it provides personalized care coordination to help navigate treatment. The company is a public benefit corporation focused on sustainable access to high-cost one-time curative therapies, aiming to align incentives among payers, providers, employers, and manufacturers while improving healthcare affordability and value-based care.
Explore more opportunities at Aradigm